Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation

In adrenoleukodystrophy (ALD), contrast enhancement (CE) is a disease activity marker, but there is uncertainty about the optimal delay, if any, between contrast injection and magnetic resonance imaging (MRI) acquisition to avoid false-negative results. We acquired axial two-dimensional (2D) and thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moscatelli, Marco, Benzoni, Chiara, Doniselli, Fabio M., Verri, Mattia, Pascuzzo, Riccardo, Aquino, Domenico, Mazzi, Federica, Erbetta, Alessandra, Salsano, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545606/
https://www.ncbi.nlm.nih.gov/pubmed/37782421
http://dx.doi.org/10.1186/s41747-023-00373-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545606/
https://www.ncbi.nlm.nih.gov/pubmed/37782421
http://dx.doi.org/10.1186/s41747-023-00373-6

Ejemplares similares